These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Reassessing the use of vasodilators in heart failure. Cole RT; Gheorghiade M; Georgiopoulou VV; Gupta D; Marti CN; Kalogeropoulos AP; Butler J Expert Rev Cardiovasc Ther; 2012 Sep; 10(9):1141-51. PubMed ID: 23098150 [TBL] [Abstract][Full Text] [Related]
45. Medical management of chronic heart failure: inotropic, vasodilator, or inodilator drugs? Lang R Am Heart J; 1990 Dec; 120(6 Pt 2):1558-64. PubMed ID: 1978981 [TBL] [Abstract][Full Text] [Related]
46. Mathematical model of cardiovascular mechanics for diagnostic analysis and treatment of heart failure: Part 2. Analysis of vasodilator therapy and planning of optimal drug therapy. Tsuruta H; Sato T; Ikeda N Med Biol Eng Comput; 1994 Jan; 32(1):12-8. PubMed ID: 8182956 [TBL] [Abstract][Full Text] [Related]
47. Translational potential of thyroid hormone and its analogs. Arsanjani R; McCarren M; Bahl JJ; Goldman S J Mol Cell Cardiol; 2011 Oct; 51(4):506-11. PubMed ID: 21215270 [TBL] [Abstract][Full Text] [Related]
48. Drug therapy of heart failure. Stanley R J Cardiovasc Nurs; 1990 May; 4(3):17-34. PubMed ID: 2184198 [TBL] [Abstract][Full Text] [Related]
49. New drugs in the treatment of heart failure. Brown L Clin Exp Pharmacol Physiol; 1995 Nov; 22(11):829-32. PubMed ID: 8593738 [TBL] [Abstract][Full Text] [Related]
50. [Treatment of acute heart failure in infants]. Chéron G; Le Masne A Arch Pediatr; 1996 Feb; 3(2):176-9. PubMed ID: 8785541 [TBL] [Abstract][Full Text] [Related]
51. Vasodilators: an advance in management of congestive heart failure. Merrill AJ J Med Assoc Ga; 1977 May; 66(5):323-7. PubMed ID: 864341 [No Abstract] [Full Text] [Related]
53. Newer positive inotropic agents in the treatment of chronic cardiac failure. Current status and future directions. Weber KT; Gill SK; Janicki JS; Maskin CS; Jain MC Drugs; 1987 May; 33(5):503-19. PubMed ID: 3297622 [TBL] [Abstract][Full Text] [Related]
54. The value of positive inotropy in acute and chronic heart failure. Erdmann E J Cardiovasc Pharmacol; 1989; 14 Suppl 3():S36-41. PubMed ID: 2478802 [TBL] [Abstract][Full Text] [Related]
55. Heart failure: mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention. Francis GS; Cohn JN FASEB J; 1990 Oct; 4(13):3068-75. PubMed ID: 2210153 [TBL] [Abstract][Full Text] [Related]
56. Clinical management of the cardiovascular failure in sepsis. De Backer D; Scolletta S Curr Vasc Pharmacol; 2013 Mar; 11(2):222-42. PubMed ID: 23506500 [TBL] [Abstract][Full Text] [Related]
57. Twenty-five years of treatment of circulatory failure. Foëx P Resuscitation; 1980 Dec; 8(4):263-76. PubMed ID: 6113627 [TBL] [Abstract][Full Text] [Related]
58. Medical therapy for chronic heart failure. Krum H; Teerlink JR Lancet; 2011 Aug; 378(9792):713-21. PubMed ID: 21856485 [TBL] [Abstract][Full Text] [Related]
59. "Silent" heart failure as observed by a French cardiologist. Castaigne A Am J Cardiol; 1990 Jun; 65(23):54K-57K. PubMed ID: 2353672 [TBL] [Abstract][Full Text] [Related]
60. Current therapeutic principles in the acute management of severe congestive heart failure. Poole-Wilson PA Am J Cardiol; 1988 Aug; 62(5):4C-8C. PubMed ID: 3044059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]